- Investing Ideas
- /
- German Undervalued Stocks Based On Cash Flows
German Undervalued Stocks Based On Cash Flows
Results
16
5 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
16 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
SBS | €27.95 | -9.4% | -33.8% | €339.8m | €41.00 | PE33.9x | E25.4% | 2.0% | Healthcare | ||
CEK | €5.15 | -8.0% | 20.0% | €43.5m | €7.94 | PE32.9x | E25.1% | 2.9% | Tech | ||
SAX New | €47.46 | -3.5% | -10.0% | €2.7b | €73.61 | PE23x | E29.2% | 3.9% | Media | ||
FYB | €47.05 | 0.2% | -23.6% | €830.8m | €85.67 | PE13x | E31.5% | n/a | Pharmaceuticals & Biotech | ||
R3NK | €20.50 | 8.6% | n/a | €2.0b | €31.54 | PE100.3x | E39.8% | 1.5% | Capital Goods | ||
ISHA New | €1.94 | 0.5% | 28.1% | €28.3m | €2.80 | PS0.7x | E83.3% | n/a | Software | ||
GXI | €70.15 | -5.4% | -17.1% | €2.4b | €114.45 | PE21.2x | E21.7% | 1.8% | Pharmaceuticals & Biotech | ||
SHA0 | €4.40 | 5.5% | -13.2% | €4.2b | €6.04 | PE28.9x | E71.5% | 10.2% | Automobiles | ||
ENR New | €45.62 | -1.5% | 319.1% | €35.7b | €42.03 | PE30.1x | E23.5% | 0% | Capital Goods | ||
IXX | €37.00 | -1.6% | 20.1% | €365.4m | €54.00 | PE20x | E27.8% | 1.9% | Software | ||
PBB | €5.08 | -1.6% | -15.5% | €683.1m | €6.64 | PE10.5x | E34.1% | n/a | Diversified Financials | ||
EQS | €39.40 | 0% | 90.3% | €394.9m | €37.50 | PS5.5x | E115.5% | 0% | Software | ||
BSL | €5.30 | -3.6% | -42.2% | €162.9m | €11.26 | PS0.9x | E109.8% | 0% | Tech | ||
OT8 New | €1.63 | -1.2% | n/a | €190.9m | n/a | PE9.3x | E29.7% | n/a | Diversified Financials | ||
SUSE | €10.89 | -0.2% | -41.9% | €1.9b | €14.44 | PS3x | E117.7% | 28.4% | Software | ||
ADS New | €213.50 | -1.6% | 14.0% | €38.1b | €249.73 | PE100.1x | E38.1% | 0.3% | Consumer Durables |
Page 1 of 1